Clinical Trial Update: Effect of Cenicriviroc on HIV Neurocognitive Impairment [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cenicriviroc for HIV-associated neurocognitive impairment has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aids Dementia Complex
• Hiv-1-associated Cognitive-motor Complex

Drugs mentioned

• Cenicriviroc (cenicriviroc)

Snippet

Sponsor: University of Hawaii | Conditions: AIDS Dementia Complex, HIV-1-Associated Cognitive Motor Complex | Phase 2 | Status: COMPLETED | Results posted: 2020-08-20